2019 American Transplant Congress » Poster Session C: Liver: MELD, Allocation and Donor Issues (DCD/ECD)

6:00pm-7:00pm

Analysis Of Public Health Service Increased Risk Donors Shows No Viral Transmission In Liver Transplant Recipients And Similar Graft / Patient Survival When Compared To Non-increased Risk Donors

A. Amin, T. Ito, D. Ng, R. McMillan, J. DiNorcia, V. Agopian, F. Kaldas, H. Yersiz, R. Busuttil, D. Farmer

6:00pm-7:00pm

Donor – Recipient Size Mismatch Has No Impact on Outcomes after Deceased Donor Whole Liver Transplantation: A Single Center Analysis

A. Cabrales¹, R. Mangus¹, B. Ekser¹, L. Timsina¹, J. Fridell¹, P. Mihaylov¹, T. Nikumbh¹, M. Ghabril², M. Lacerda², C. Kubal¹

6:00pm-7:00pm

Donor Hepatitis C Seropositivity Confers Poorer Post-transplant Outcomes In Recipients Of Marginal Livers In The Post-hepatitis C Treatment Era

M. B. Shah, M. Gupta, X. Mei, R. Gedaly

6:00pm-7:00pm

Early Allograft Dysfunction in High Acuity Liver Transplant Recipients

T. Ito, M. Lu, A. Murray, D. S. Graham, J. DiNorcia, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas

6:00pm-7:00pm

Factors Associated with the Acceptance of Livers for Liver Transplantation: Validation of the Discard Risk Index in the Eurotransplant Region

J. D. Boer¹, H. Putter², J. J. Blok³, N. Cambridge¹, S. Van den Berg¹, U. Samuel¹, G. Berlakovich⁴, M. Guba⁵, A. E. Braat³

6:00pm-7:00pm

Finding Opportunities for Increased Donation after Circulatory Death Liver Utilization: Results of an American Society of Transplant Surgeons/Association of Organ Procurement Organizations Survey

M. Hobeika¹, R. Glazner², D. Foley¹, S. Hanish¹, C. Quintini¹, E. Eidbo², D. Axelrod¹

6:00pm-7:00pm

Gender Disparities In Cirrhosis: New Findings In A Large Pretransplant Population

N. Mazumder, K. Atiemo, A. Daud, L. Zhao, M. Abecassis, J. Levitsky, D. P. Ladner

6:00pm-7:00pm

Geographic Disparities in Liver Supply/Demand Ratio within Fixed-Distance and Fixed-Person Circles

C. Haugen¹, T. Ishaque¹, A. Sapirstein¹, D. Segev¹, S. Gentry²

6:00pm-7:00pm

Identifying a Clinically Relevant Cut-Off for Height That is Associated with a Higher Risk of Waitlist Mortality in Liver Transplant Candidates

J. Ge, J. C. Lai

6:00pm-7:00pm

Impact Of Aggressive Utilization Of Liver Allografts On Outcomes

A. Rana, M. Kueht, N. Galvan, R. Cotton, C. O'Mahony, J. Goss

6:00pm-7:00pm

Impact of Enteric Vancomycin Resistant Enterococcus Colonization on Waitlist Outcomes among Liver Transplant Candidates

E. Aldag, R. Pedersen, V. Gunabushanam, A. Sahajpal, T. J. Dilworth

6:00pm-7:00pm

Impact of MELD-Na Course (Delta MELD-Na) on Outcome after Liver Transplantation

G. Silberhumer¹, G. Gyoeri¹, L. Unger², G. Harpain¹

6:00pm-7:00pm

Impact of Revised Policy for Hepatocellular Carcinoma MELD Exception Points on Recurrence after Liver Transplantation

P. Le¹, L. McClelland¹, K. Knapp¹, T. Xu¹, S. Pelletier²

6:00pm-7:00pm

Increasing Incidence and Transplantation of Individuals Listed with Alcoholic Liver Disease

E. L. Godfrey¹, A. Rana², J. A. Goss²

6:00pm-7:00pm

Increasing the Number of Liver Transplants through Active Review of Offers Turned Down

M. L. Melcher, C. A. Bonham, A. Gallo, W. Concepcion, I. Jacobson, C. O. Esquivel

6:00pm-7:00pm

Liver Circle-Based Allocation: LSAM Modeling Results

D. Schladt¹, T. Weaver¹, J. Pyke¹, A. Herreid¹, B. Thompson¹, B. Kasiske¹, J. Snyder¹, W. Kim², J. Lake³, A. Israni¹, J. Heimbach⁴

6:00pm-7:00pm

Liver Transplant Candidates Derive a Survival Benefit from Accepting a Macrosteatotic Liver

K. Jackson, M. Bowring, C. Haugen, C. Holscher, L. Liyanage, S. Ottmann, B. Philosophe, A. Massie, D. Segev, A. Cameron, J. Garonzik-Wang

6:00pm-7:00pm

Liver Transplantation in Acute Hepatic Insufficiency Induced by Imatinib

A. I. David¹, D. N. Alvarenga de Rezende², M. C. Fantauzzi³, T. Di Santi³, N. C. Confuorto³, G. T. Martinho³, P. S. Antunes³

6:00pm-7:00pm

MELD-Na Alterations on the Liver Transplant Waiting List and Its Impact on Listing Outcome

G. Silberhumer¹, G. Gyoeri¹, L. Baumann¹, S. Zehetmayer², T. Soliman¹, G. Berlakovich¹

6:00pm-7:00pm

Microsteatosis in Livers from Donation after Circulatory Death (DCD) Donors is Associated with Inferior Graft and Patient Survival Following Liver Transplantation (LTX)

N. Bath, G. Leverson, D. Foley

6:00pm-7:00pm

Moving from Local Allocation to National Allocation Using Gravity Model

F. Bayer¹, B. Audry², C. Antoine², C. Jasseron², C. Legeais², O. Bastien², C. Jacquelinet¹

6:00pm-7:00pm

Patients With Persistently Low MELD-Na Scores Continue To Be At Risk Of Liver Related Death

N. Mazumder, K. Atiemo, S. Montag, A. Daud, A. Kho, M. Abecassis, J. Levitsky, D. Ladner

6:00pm-7:00pm

Risk Factors for Graft Loss Vary with Recipient MELD Score in Liver Transplantation

J. A. Steggerda¹, M. B. Bloom¹, T. Todo², T. V. Brennan², N. N. Nissen², A. S. Klein², I. K. Kim²

6:00pm-7:00pm

Share 21 Rather Than Share 15: Balancing Transplant Opportunity without Compromising Waitlist Outcomes

S. Nagai¹, L. C. Chau¹, M. Abouljoud¹, K. Collins¹, S. Jafri², M. Safwan¹, D. Moonka²

6:00pm-7:00pm

Taking a Step toward Standardization: Results of an American Society of Transplant Surgeons/Association of Organ Procurement Organizations Survey of Donation after Circulatory Death Liver Recovery Practices

M. Hobeika¹, R. Glazner², D. Foley¹, S. Hanish¹, C. Quintini¹, E. Eidbo², D. Axelrod¹

6:00pm-7:00pm

The Feasibility Of Donation After Cardiac Death In Liver Transplantation: A Registry Analysis

A. C. Gruessner, R. Misawa, A. Masi, Z. Moghadamyeghaneh, J. F. Renz, R. W. Gruessner

6:00pm-7:00pm

The Impact of Share 35 on Living Donor Liver Transplant Utilization in the United States: Analysis of UNOS Data

H. J. Braun, J. L. Dodge, J. D. Grab, R. Hirose, P. G. Stock, N. L. Ascher

6:00pm-7:00pm

The Power of Young Donor Liver; Elixir of Life for Sick Liver Transplant Recipient

J. Kusakabe¹, J. McVey², D. J. Firl², M. Fujiki², F. N. Aucejo², C. Quintini², K. Hashimoto², K. Sasaki²

6:00pm-7:00pm

The Utility Of Intraoperative Vascular Anastomotic Inflow Measurements In Donation After Circulatory Death (DCD) Liver Transplantation

A. Nair, L. Coromina Hernandez, K. Sasaki, C. Kwon, T. Diago Uso, M. Fujiki, F. Aucejo, K. Hashimoto, B. Eghtesad, C. Miller, C. Quintini

6:00pm-7:00pm

Twin Epidemics: Drug Overdoses And Suicides Are Increasingly Fueling The United States Donor Liver Supply

M. Goss¹, M. Kueht¹, N. Galvan¹, J. Reece², A. Rana¹

6:00pm-7:00pm

Use, Safety and Effectiveness of Hepatitis B Virus NAT-Positive Donor Livers in the Current Era

T. C. Lee, K. Safdar, L. K. Winer, M. C. Morris, A. Kassam, K. Luckett, R. Quillin III, K. Bari, N. Anwar, S. A. Shah

6:00pm-7:00pm

Validation Of The Optimized Prediction Of Mortality (Opom) Machine Learning Model For Non-hepatocellular Carcinoma Candidates Awaiting Liver Transplant

L. Lau¹, X. Xie², F. Jia², P. D. Greig¹, T. C. Chan²

6:00pm-7:00pm

When to Transplant for Wilson’s Disease: A Review

M. Flanagan, S. Koohmaraie, M. Kueht, R. Cotton, C. O'Mahony, A. Rana, J. Goss, N. Galvan